Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018

Considering the complexity of second-line anti-tuberculosis (TB) treatment regimens, the management of drug-resistant TB (DR-TB) in Georgia remains a major challenge. Since the introduction of new and repurposed anti-TB medications, the implementation of active TB Drug Safety Monitoring (aDSM) was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Buziashvili, Mariana, Davtyan, Hayk, Sereda, Yuliia, Denisiuk, Olga, Gozalov, Ogtay, Lomtadze, Nino, Hovhannesyan, Arax
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396672/
https://www.ncbi.nlm.nih.gov/pubmed/33470083
http://dx.doi.org/10.4081/monaldi.2021.1649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396672/
https://www.ncbi.nlm.nih.gov/pubmed/33470083
http://dx.doi.org/10.4081/monaldi.2021.1649

Ejemplares similares